Rita S. Axelrod MD

Oncology•Philadelphia, PA

Professor Medical Oncology Thomas Jefferson University; Director, Jefferson Oncology Group

Join to View Full Profile

925 Chestnut StSte 320APhiladelphia, PA 19107
Phone+1 215-955-8874
Fax+1 215-955-2340

Education & Training

Main Line Health System/Lankenau Medical CenterFellowship, Hematology and Medical Oncology, 1975 - 1976
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1974 - 1975
Medical College of GeorgiaResidency, Internal Medicine, 1972 - 1973
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1970 - 1971
New York University School of MedicineClass of 1970

Certifications & Licensure

PA State Medical License 1974 - 2026
DE State Medical License 2017 - 2025
NJ State Medical License 1985 - 2025
NY State Medical License 1971 - 2014
GA State Medical License 1972 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
America's Top Doctors Castle Connolly, 2009-2014
Philadelphia Magazine Castle Connolly, 2005-2014
America's Top Doctors for Cancer Castle Connolly, 2008-2013
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jul 19
COMPLETED
PHASE3
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01
ACTIVE_NOT_RECRUITING
PHASE3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
ACTIVE_NOT_RECRUITING
PHASE3
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation Start of enrollment: 2004 Oct 01
Completed
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy Start of enrollment: 2013 Nov 11
Completed
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jul 22
Completed
Avelumab with or Without Cetuximab in Treating Patients with Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 Jun 17
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.
Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena, Anastasia Nikitina, Anastasia Sobol
Clinical Cancer Research. 2025-02-03
3 citations
Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
Ramez Philips, Angela Alnemri, Dev Amin, Jena Patel, Michael C Topf
Cancer. 2024-03-15
1 citations
In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the...
Ayesha S Ali, Gregor Manukian, Jennifer M Johnson, Ioannis Vathiotis, Rita Axelrod
International Journal of Radiation Oncology, Biology, Physics. 2023-09-01

Press Mentions

Her Duty to HumanityOctober 29th, 2018

Professional Memberships

American Society of Clinical Oncology - ASCO
Member